Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002310951 | SCV000319614 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2024-05-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000493215 | SCV000582567 | uncertain significance | not provided | 2023-04-14 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign in association with a NOTCH1-related disorder to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 24113472, 28377411) |
Labcorp Genetics |
RCV000692256 | SCV000820070 | benign | Adams-Oliver syndrome 5 | 2024-12-26 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000766054 | SCV000897510 | uncertain significance | Aortic valve disease 1; Adams-Oliver syndrome 5 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000692256 | SCV002553298 | uncertain significance | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270161 | SCV002553299 | uncertain significance | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genetics and Molecular Pathology, |
RCV002270161 | SCV002761413 | uncertain significance | Aortic valve disease 1 | 2021-03-31 | criteria provided, single submitter | clinical testing | The NOTCH1 c.6521A>G variant is classified as VUS (PM2) Arginine is observed at this location in many mammals so likely to be tolerated. |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000493215 | SCV001954830 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000493215 | SCV001964828 | likely benign | not provided | no assertion criteria provided | clinical testing |